DFW Portfolio Company, Sebela Pharmaceuticals, Acquires Braintree Laboratories

DFW Capital Partners (“DFW”) announced today that its portfolio company, Sebela Pharmaceuticals (“Sebela”), has completed the acquisition of Braintree Laboratories Inc., (“Braintree”), a privately held specialty pharmaceutical company based in Boston, Massachusetts. Braintree develops, manufactures and markets specialty pharmaceuticals in gastroenterology. Braintree’s market-leading colonoscopy prep franchise includes SUPREP™, the #1 prescribed colon prep since 2013.… Read more »

DFW Capital Partners closes investment in ReSource Pro

DFW Capital Partners (“DFW”) announced today that it has completed an investment in ReSource Pro Holdings, LLC (“ReSource Pro” or the “Company”). ReSource Pro is the leader in providing strategic business process management and outsourcing to the insurance industry – focusing on delivering dedicated back-office and business analytics support to insurance agencies, managing general agents,… Read more »

DFW Capital Partners Closes Strategic Investment in INSIGHT2PROFIT

DFW Capital Partners (“DFW”) is pleased to announce that it recently completed a strategic investment in INSIGHT2PROFIT. INSIGHT2PROFIT is a fast growing technology-enabled service company focused on delivering sustainable revenue and EBITDA growth through implementation and management of pricing and profit strategies. INSIGHT2PROFIT has locations in Cleveland, Ohio and Chicago, Illinois. “We are excited about… Read more »

Saol Therapeutics Acquires Three Hyperimmune Products from Aptevo Therapeutics

DFW Capital Partners is pleased to announce that its existing portfolio company, Saol Therapeutics, has acquired to acquire three marketed hyperimmune products, WinRho® SDF (Rh0(D) Immune Globulin Intravenous (Human)), HepGam B® (Hepatitis B Immune Globulin Intravenous (Human)) and VARIZIG® (Varicella Zoster Immune Globulin (Human)) from Aptevo Therapeutics Inc. (Nasdaq: APVO). The deal includes both upfront… Read more »

Evolution Research Group acquires Endeavor Clinical Trials

DFW Capital Partners is pleased to announce that its existing portfolio company, Evolution Research Group (“ERG”), has acquired Endeavor Clinical Trials (“ECT”), of San Antonio, Texas. ECT has over 20 years of experience conducting over 185 clinical trials, specializing in post-operative pain, neuropathic pain, podiatry, and vaccine research, among others. Endeavor Clinical Trials is comprised… Read more »

DFW Capital Partners Combines LRI and RTS into Integrated Efficiency Solutions

DFW Capital Partners (“DFW”) today announced that Integrated Efficiency Solutions (“IES”), a new holding company, has continued its commitment to the energy solutions market with its third investment. On June 30, 2017, IES acquired Retro-Tech Systems (“RTS”) as a wholly owned subsidiary. RTS, which includes RTS Lighting, RTS Water, RTS Utility Metering, and RTS Building… Read more »

Superior Controls Merges with Banks Integration Group

DFW Capital Partners is pleased to announce that its existing portfolio company, Superior Controls, a leading control system integrator of custom industrial automation and IT solutions, has merged with Banks Integration Group (“Banks Integration”), a leading systems integrator headquartered in Vacaville, CA outside San Francisco.  The combination, which is the first investment of its kind for… Read more »